WO2007017894A3 - PREPARATION OF NOVEL CRYSTALLINE η(ETA) FORM OF PERINDOPRIL ERBUMINE - Google Patents

PREPARATION OF NOVEL CRYSTALLINE η(ETA) FORM OF PERINDOPRIL ERBUMINE Download PDF

Info

Publication number
WO2007017894A3
WO2007017894A3 PCT/IN2006/000156 IN2006000156W WO2007017894A3 WO 2007017894 A3 WO2007017894 A3 WO 2007017894A3 IN 2006000156 W IN2006000156 W IN 2006000156W WO 2007017894 A3 WO2007017894 A3 WO 2007017894A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
novel crystalline
eta
perindopril erbumine
erbumine
Prior art date
Application number
PCT/IN2006/000156
Other languages
French (fr)
Other versions
WO2007017894B1 (en
WO2007017894A2 (en
Inventor
Ashish Ujagare
D A Kochrekar
Pushpalata Sarjekar
Original Assignee
Arch Pharmalabs Ltd
Ashish Ujagare
D A Kochrekar
Pushpalata Sarjekar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arch Pharmalabs Ltd, Ashish Ujagare, D A Kochrekar, Pushpalata Sarjekar filed Critical Arch Pharmalabs Ltd
Publication of WO2007017894A2 publication Critical patent/WO2007017894A2/en
Publication of WO2007017894A3 publication Critical patent/WO2007017894A3/en
Publication of WO2007017894B1 publication Critical patent/WO2007017894B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A novel crystalline (η) form of Perindopril erbumine of Formula (II) of characteristic 2θ values 4.07, 5.26, 9.46, 15.75, 21.04, 21.35, 23.15, 24.13, 26.38, 31.8, and 27.18. More particularly the present invention relates to a process for the preparation of the novel crystalline (η) form of Perindopril erbumine of Formula (II).
PCT/IN2006/000156 2005-05-05 2006-05-04 PREPARATION OF NOVEL CRYSTALLINE η(ETA) FORM OF PERINDOPRIL ERBUMINE WO2007017894A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN561/MUM/2005 2005-05-05
IN561MU2005 2005-05-05

Publications (3)

Publication Number Publication Date
WO2007017894A2 WO2007017894A2 (en) 2007-02-15
WO2007017894A3 true WO2007017894A3 (en) 2007-05-10
WO2007017894B1 WO2007017894B1 (en) 2007-07-05

Family

ID=37725314

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2006/000156 WO2007017894A2 (en) 2005-05-05 2006-05-04 PREPARATION OF NOVEL CRYSTALLINE η(ETA) FORM OF PERINDOPRIL ERBUMINE

Country Status (1)

Country Link
WO (1) WO2007017894A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI22543A (en) * 2007-06-27 2008-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto New salts of perindopril
AU2013201812B2 (en) * 2007-06-27 2015-04-02 Les Laboratoires Servier Salts of perindopril
PT105315B (en) 2010-09-29 2013-01-16 Inst Superior Tecnico A NEW CRYSTALIN HYDRATE FORM OF PERINDOPRIL ERBUMINE, METHODS FOR PREPARATION AND USE IN PHARMACEUTICAL PREPARATIONS

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001083439A2 (en) * 2000-07-06 2001-11-08 Les Laboratoires Serviers Novel $g(y) crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same.
WO2001087836A1 (en) * 2000-07-06 2001-11-22 Les Laboratoires Servier Novel $g(b crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same
WO2001087835A1 (en) * 2000-07-06 2001-11-22 Les Laboratoires Servier Α crystalline form of perindopril tert-butylamine salt
WO2004113293A1 (en) * 2003-06-24 2004-12-29 Les Laboratoires Servier Novel crystalline forms of perindopril erbumine
WO2005037788A1 (en) * 2003-10-21 2005-04-28 Lupin Ltd. Novel method for preparation of crystalline perindopril erbumine
WO2005068425A1 (en) * 2004-01-14 2005-07-28 Lek Pharmaceuticals D.D. New crystalline form of perindopril
WO2005108365A1 (en) * 2004-05-07 2005-11-17 Glenmark Pharmaceuticals Limited Processes for the preparation of alpha polymorph of perindopril erbumine

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001083439A2 (en) * 2000-07-06 2001-11-08 Les Laboratoires Serviers Novel $g(y) crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same.
WO2001087836A1 (en) * 2000-07-06 2001-11-22 Les Laboratoires Servier Novel $g(b crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same
WO2001087835A1 (en) * 2000-07-06 2001-11-22 Les Laboratoires Servier Α crystalline form of perindopril tert-butylamine salt
WO2004113293A1 (en) * 2003-06-24 2004-12-29 Les Laboratoires Servier Novel crystalline forms of perindopril erbumine
WO2005037788A1 (en) * 2003-10-21 2005-04-28 Lupin Ltd. Novel method for preparation of crystalline perindopril erbumine
WO2005068425A1 (en) * 2004-01-14 2005-07-28 Lek Pharmaceuticals D.D. New crystalline form of perindopril
WO2005108365A1 (en) * 2004-05-07 2005-11-17 Glenmark Pharmaceuticals Limited Processes for the preparation of alpha polymorph of perindopril erbumine

Also Published As

Publication number Publication date
WO2007017894B1 (en) 2007-07-05
WO2007017894A2 (en) 2007-02-15

Similar Documents

Publication Publication Date Title
WO2007076245A3 (en) Novel hydrogen sulfate salt
WO2003070725A3 (en) Process for preparing indolinone derivatives
WO2007001934A3 (en) Molecular sieve ssz-56 composition of matter and synthesis thereof
UA99896C2 (en) Process for the preparaton of glucopyranosyl-substituted phenyl derivatives, intermediates and processes for the production thereof
WO2007146622A8 (en) Molecular sieve ssz-75 composition of matter and synthesis thereof
MX2007004698A (en) Asymmetric synthesis of substituted dihydrobenzofurans.
WO2009000442A3 (en) Processes for the preparation of pyrazoles
WO2010088243A3 (en) Processes using molecular sieve ssz-79
WO2007115210A3 (en) Non-starchy rice bran polysaccharides
WO2007066158A3 (en) HIGH PURITY 17α-CYANOMETHYL-17β-HYDROXY-ESTRA-4,9-DIENE-3-ONE AND PROCESS FOR THE SYNTHESIS THEREOF
WO2009068463A3 (en) Process for the preparation of isoindole derivatives as well as a process for the preparation of their intermediates
WO2010059297A3 (en) Processes using molecular sieve ssz-82
NO20071012L (en) Process for Preparation of D-Erythro-2,2-Difluoro-2-Deoxy-1-Oxoribose Derivative
WO2007047671A3 (en) Tetrahydroquinolines, synthesis thereof, and intermediates thereto
WO2005077902A3 (en) Methods for the synthesis of pyridoxamine
WO2007016029A3 (en) Diazepinoquinolines, synthesis thereof, and intermediates thereto
WO2007002722A3 (en) Synthesis of anastrozole and purification of one of its intermediate
WO2007017894A3 (en) PREPARATION OF NOVEL CRYSTALLINE η(ETA) FORM OF PERINDOPRIL ERBUMINE
WO2007017893A3 (en) Preparation of novel crystalline form of perindopril erbumine monohydrate
WO2007072496A3 (en) A process to prepare sucralose
WO2004048380A8 (en) Process for the synthesis of ganciclovir
ZA200800138B (en) Process for the preparation of crystalline perindopril
WO2008059513A3 (en) Compounds suitable as modulators of hdl
WO2007057316A3 (en) Novel process for the preparation of thoc
UA92613C2 (en) Process for the preparation of crystalline form d of perindopril erbumine

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

NENP Non-entry into the national phase

Ref country code: RU

WWW Wipo information: withdrawn in national office

Country of ref document: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06809917

Country of ref document: EP

Kind code of ref document: A2